Drugs · Brain health technique
Antihypertensives
Evidence grade: Context Dependent

Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers (amlodipine, diltiazem), thiazide diuretics (chlorthalidone, hydrochlorothiazide), and beta-blockers (metoprolol, carvedilol).
- Practice
- Drugs
- Principle
- Treatment
- Tactic
- Metabolic & Vascular Optimization Drugs
- Health domains
- vascular
- Evidence grade
- Context Dependent
- Strength of evidence
- Medium
- Cost
- High
- Effort
- Low
- Time commitment
- Low
How to practice Antihypertensives
Monitor blood pressure regularly and work with a clinician to tailor therapy. Combine medication with diet (DASH or Mediterranean), sodium reduction, and regular physical activity. Early and sustained control in midlife provides the greatest cognitive benefit. Avoid overtreatment causing hypotension, which can reduce brain perfusion.
The evidence behind Antihypertensives
High blood pressure is a leading risk factor for heart attack, stroke, and kidney disease. Lowering blood pressure with medicine reduces the risk of heart attack and stroke. These drugs help keep your blood vessels flexible and blood flowing through your smallest vessels. The evidence for these benefits is robust and consistent.
Impact on brain health
High blood pressure is one of the strongest modifiable risk factors for dementia and cognitive decline. Trials in adults with high blood pressure show that treating to a systolic pressure (the top number) below 120 mmHg lowers the risk of mild cognitive impairment more than a standard target does. The same trials show less white-matter damage, likely because steady blood flow means fewer oxygen shortages and less inflammation in brain cells.
Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science
More Drugs techniques
Pair this with other habits from the same practice.

Evidence grade: Context Dependent
Anti-Amyloid Monoclonal Antibodies
FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

Evidence grade: Context Dependent
GLP-1 Receptor Agonists
A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.

Evidence grade: Context Dependent
Lipid-Lowering Drugs
Therapies that reduce LDL cholesterol and vascular inflammation, including statins (atorvastatin, rosuvastatin, simvastatin), PCSK9 inhibitors (alirocumab, evolocumab), and ezetim…
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.